Skip to main content
logo
Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
21.89
-0.48 (-2.15%)
At close: Sep 11, 2026

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
8,0279,9889,20014,649--
Market Cap Growth
-35.03%8.57%-37.20%---
Enterprise Value
7,3018,7207,40512,246--
Last Close Price
21.8927.2425.0939.95--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
23.7243.29305.7012091.50--
PB Ratio
6.266.304.335.26--
P/TBV Ratio
6.496.484.425.35--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
21.5737.79246.0410108.38--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.880.670.390.2326.891.83
Net Debt / Equity Ratio
-0.57-0.73-0.76-0.8217.030.42
Net Debt / EBITDA Ratio
1.372.202.063.05-0.87-0.48
Net Debt / FCF Ratio
1.062.732.604.86-1.53-0.37
Asset Turnover
0.120.080.010.0000.05
Inventory Turnover
0.240.230.11-0.040.80
Quick Ratio
4.844.7414.1221.332.275.15
Current Ratio
5.455.1715.0522.153.166.15
Return on Equity (ROE)
-36.14%-28.87%-32.47%-56.97%-337.99%-
Return on Assets (ROA)
-12.58%-11.87%-15.62%-21.82%-38.85%-25.14%
Return on Capital Employed (ROCE)
-25.20%-23.10%-28.30%-23.00%-73.10%-32.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.01%-5.36%-8.67%-5.47%--
FCF Yield
-8.57%-4.24%-6.75%-3.20%--
Buyback Yield / Dilution
0.03%0.14%-14.63%-16.79%0.32%-